hand
foot
mouth
diseas
hfmd
febril
exanthemat
diseas
typic
symptom
atyp
symptom
typic
symptom
hfmd
includ
flat
discolor
spot
bump
may
blister
hand
feet
mouth
occasion
buttock
groin
even
inflamm
heart
fluid
lung
bleed
lung
inflamm
brain
inflamm
mening
acut
flaccid
paralysi
sometim
accompani
death
children
younger
year
age
epidemiolog
result
show
typic
hfmd
usual
caus
enteroviru
coxsackieviru
chan
et
al
wang
et
al
atyp
hfmd
hand
character
sever
rash
onychomadesi
young
children
higher
rate
infect
adult
usual
induc
coxsackieviru
increas
epidemiolog
data
indic
outbreak
hfmd
markedli
increas
worldwid
recent
year
gao
et
al
laga
et
al
li
j
et
al
li
w
et
al
mirand
et
al
howev
current
vaccin
develop
drug
develop
basic
research
hfmd
princip
target
therefor
strategi
prevent
treat
scarc
even
current
knowledg
infect
pathogen
mechan
immunogen
remain
limit
part
pathogen
mechan
mani
virus
known
control
host
cell
cycl
maxim
replic
exampl
found
among
dna
virus
retrovirus
rna
virus
small
dna
virus
simian
viru
decaprio
et
al
adenoviru
howe
et
al
eckner
et
al
human
papillomaviru
wer
et
al
well
larg
dna
virus
herpesvirus
flemington
arrest
host
cell
cycl
util
host
resourc
vpr
protein
retroviru
human
immunodefici
viru
type
respons
accumul
cell
phase
et
al
goh
et
al
among
rna
virus
coronaviru
famili
viru
infecti
bronchiti
viru
ibv
arrest
cell
viral
prolifer
dove
et
al
li
et
al
mous
hepat
viru
mhv
chen
makino
sever
acut
respiratori
syndrom
coronaviru
sarscov
yuan
et
al
enteroviru
wang
et
al
induc
cell
cycl
arrest
phase
etiolog
agent
typic
hfmd
induc
cell
cycl
arrest
phase
viral
product
nonstructur
protein
yu
et
al
howev
whether
atyp
hfmd
agent
regul
host
cell
cycl
clear
cell
cycl
progress
eukaryot
control
intric
mechan
involv
cdk
bind
correspond
cyclin
regulatori
subunit
tightli
sequenti
order
phase
cyclin
cyclind
cyclin
associ
predominantli
promot
progress
sphase
entri
sherr
upregul
inhibit
activ
complex
arrest
cell
cycl
phase
sherr
robert
subsequ
cyclina
cyclin
combin
mainli
promot
sphase
progress
lundberg
weinberg
cyclinb
regul
mitot
entri
yu
et
al
virus
well
known
manipul
cell
cycl
progress
regul
cyclin
cdk
express
caffarelli
et
al
adeyemi
pintel
yu
et
al
potenti
effect
cell
cycl
regul
unknown
studi
examin
potenti
effect
infect
host
cell
cycl
data
demonstr
replic
arrest
cell
cycl
phase
convers
cell
cycl
arrest
phase
provid
favor
condit
product
demonstr
nonstructur
protein
respons
arrest
result
advanc
understand
pathogen
mechan
provid
potenti
target
treatment
prevent
hfmd
human
embryon
kidney
cell
hek
cell
human
rhabdomyosarcoma
rd
cell
atcc
purchas
atcc
manassa
va
usa
cell
grown
dmem
dulbecco
modifi
eagl
medium
hyclon
logan
ut
usa
supplement
fb
fetal
bovin
serum
gibco
brl
grand
island
ny
usa
strain
http
provid
jilin
provinci
center
diseas
control
prevent
changchun
china
virus
propag
rd
cell
supernat
collect
store
previou
studi
yu
et
al
wang
et
al
previou
studi
yu
et
al
wang
et
al
trizol
invitrogen
use
extract
total
rna
accord
supplier
instruct
highcapac
cdna
revers
transcript
kit
appli
biosystem
use
gener
cdna
oligod
primer
takara
primer
shown
tabl
gene
clone
use
product
revers
transcript
reaction
templat
forward
primer
ha
tag
primer
restrict
site
engin
rtpcr
product
subsequ
digest
correspond
restrict
enzym
clone
correspond
restrict
site
plasmid
accord
previou
studi
yu
et
al
wang
et
al
plasmid
includ
empti
vector
lipofectamin
invitrogen
transfect
cell
cell
cultur
dish
dosedepend
experi
replenish
empti
plasmid
maintain
final
concentr
plasmidwel
h
transfect
cell
collect
cell
cycl
analysi
describ
zhong
et
al
viral
titer
microtitr
assay
determin
measur
rd
cell
viru
serial
prepar
dilut
viruswel
inocul
octupl
plate
cytopath
effect
measur
per
day
experiment
endpoint
reach
determin
accord
reedmuench
method
reed
muench
base
virus
produc
plaqu
form
unitsml
previou
studi
reed
muench
yu
et
al
cell
mockinfect
infect
moi
h
viru
absorpt
cell
wash
pb
cell
cultur
fresh
cultur
medium
synchron
cell
phase
rd
cell
depriv
serum
h
et
al
approxim
cellswel
plate
maintain
serumfre
medium
h
viru
infect
fresh
dmem
ad
releas
cell
previou
studi
yu
et
al
wang
et
al
arrest
rd
cell
synchron
serum
depriv
h
et
al
sphase
synchron
cell
treat
mm
thymidin
sigma
helt
harri
h
arrest
rd
cell
treat
ngml
nocodazol
sigma
wang
et
al
h
sustain
correspond
cellcycl
arrest
viru
infect
fresh
medium
serumfre
fresh
medium
mm
thymidin
fresh
medium
ngml
nocodazol
retreat
indic
time
previou
studi
yu
et
al
wang
et
al
accord
previou
studi
yu
et
al
wang
et
al
cellular
dna
content
measur
fluorescenceactiv
cell
sort
fac
propidium
iodid
pi
stain
previou
studi
yu
et
al
wang
et
al
virusinfect
mockinfect
cell
collect
indic
time
follow
antibodi
use
proteintech
cell
signal
anticyclind
cell
signal
cell
signal
cell
signal
cell
signal
proteintech
proteintech
santa
cruz
boster
genetex
antihiston
genscript
secondari
antibodi
mous
rabbit
obtain
jackson
immuno
research
accord
previou
studi
yu
et
al
wang
et
al
intracellular
viral
genom
rna
detect
target
primer
tabl
fold
chang
calcul
rel
gapdh
use
method
statist
differ
analyz
use
student
ttest
analys
except
dosedepend
test
pearson
correl
coeffici
use
data
present
mean
standard
deviat
sd
pvalu
consid
statist
signific
assess
whether
manipul
cell
cycl
host
cell
cell
cycl
distribut
flow
cytometri
analyz
human
rhabdomyosarcoma
rd
cell
h
postinfect
obviou
increas
phase
observ
modfit
analysi
increas
mockinfect
cell
increas
p
data
suggest
infect
induc
accumul
meanwhil
determin
whether
arrest
exclus
rd
cell
line
human
embryon
kidney
cell
select
analysi
base
screen
cell
line
cytopath
effect
infect
cell
phase
increas
increas
p
figur
h
postinfect
found
cytophath
effect
induc
obviou
rd
cell
line
data
shown
might
explain
manipul
cell
cycl
cell
line
strongli
rd
cell
line
result
indic
effect
arrest
broadli
applic
data
indic
infect
induc
cell
cycl
arrest
phase
howev
still
unknown
whether
viral
strategi
actual
benefici
viru
explor
possibl
benefit
arrest
viral
replic
cell
synchron
phase
cultur
serumfre
medium
figur
absenc
infect
h
serum
starvat
increas
ratio
cell
p
starvedmock
vs
conmock
verifi
cell
properli
synchron
phase
figur
furthermor
absenc
serum
starvat
infect
induc
arrest
h
post
infect
p
vs
conmock
consist
result
figur
addit
absenc
serum
infect
h
increas
ratio
cell
p
vs
indic
infect
increas
phase
arrest
caus
serum
starvat
directli
assess
effect
serum
starvat
viral
rna
level
perform
quantit
realtim
pcr
qrtpcr
gene
absenc
presenc
serum
starvat
h
postinfect
viral
entri
stage
genom
level
obvious
differ
control
serumstarv
cell
p
starv
vs
con
howev
h
post
infect
viral
replic
stage
time
viral
genom
rna
discov
serumstarv
cell
control
cell
p
starv
vs
con
figur
furthermor
h
post
infect
viral
product
stage
viral
protein
level
increas
serumstarv
cell
compar
control
cell
p
starv
vs
con
figur
addit
h
infecti
particl
time
higher
total
virus
includ
supernat
intracellular
virus
phasesynchron
cell
control
cell
p
starv
vs
con
figur
result
indic
synchron
affect
viral
entri
promot
product
determin
whether
cellcyclearrestdepend
enhanc
viral
replic
specif
arrest
effect
arrest
viral
replic
assess
induc
phase
synchron
thymidin
treat
cultur
cell
figur
found
mm
thymidin
induc
obviou
phase
arrest
compar
control
treatment
p
howev
unabl
accumul
cell
phase
treat
thymidin
figur
viral
genom
rna
level
assess
qrtpcr
remain
similar
phasesynchron
cell
control
nonsynchron
cell
h
postinfect
figur
reduc
phasesynchron
cell
h
postinfect
p
thymi
vs
con
figur
consist
express
protein
phasesynchron
cell
lower
control
nonsynchron
cell
h
postinfect
p
thymi
vs
con
figur
furthermor
valu
h
postinfect
much
lower
total
virus
includ
supernat
intracellular
virus
phasesynchron
cell
control
cell
p
figur
result
indic
arrest
sphase
affect
entri
inhibit
viral
product
induc
phase
synchron
cell
treat
nocodazol
figur
nododazol
obvious
accumul
cell
phase
p
figur
furthermor
h
nocodazol
treatment
percentag
mockinfect
cell
greater
percentag
cell
howev
percentag
mockinfect
cell
nocodazol
treatment
h
less
percentag
cell
nocodazol
treatment
p
figur
result
suggest
infect
promot
entri
phase
also
examin
effect
nocodazol
genom
rna
level
h
postinfect
genom
rna
level
phasesynchron
cell
differ
control
nonsynchron
cell
figur
howev
h
postinfect
genom
level
synchron
cell
significantli
lower
control
cell
p
figur
express
phasesynchron
cell
lower
control
cell
h
postinfect
p
figur
meanwhil
total
virus
includ
supernat
intracellular
virus
obvious
lower
phasesynchron
cell
control
nonsynchron
cell
h
postinfect
p
figur
therefor
result
indic
synchron
phase
affect
viral
entri
decreas
product
therefor
enhanc
replic
upon
cell
cycl
arrest
specif
phase
follow
oridonin
activ
diterpeniod
isol
rabdosia
rubescen
util
confirm
effect
drug
viral
product
oridonin
induc
cell
cycl
arrest
phase
induc
dna
damag
zhang
et
al
zheng
et
al
differ
nocodazol
interf
polymer
microtubul
induc
phase
synchron
cell
treat
oridonin
figur
oridonin
obvious
accumul
cell
phase
p
figur
also
examin
effect
oridonin
genom
rna
level
h
postinfect
genom
rna
level
control
cell
obviou
differ
phasesynchron
cell
figur
howev
h
postinfect
genom
level
synchron
cell
lower
control
nonsynchron
cell
p
figur
express
protein
oridonintr
cell
lower
control
cell
h
postinfect
p
figur
meanwhil
total
virus
includ
supernat
intracellular
virus
phasesynchron
cell
obvious
lower
control
nonsynchron
cell
h
postinfect
p
figur
therefor
conclud
synchron
affect
viral
entri
decreas
product
therefor
enhanc
replic
upon
cell
cycl
arrest
specif
phase
result
suggest
may
induc
arrest
part
promot
exit
determin
whether
also
may
achiev
arrest
prevent
phase
entri
phase
serum
starvat
rd
cell
synchron
phase
fb
trigger
cell
cycl
reentri
figur
h
serum
stimul
mockinfect
cell
enter
phase
gradual
own
cell
cycl
distribut
normal
cell
howev
rd
cell
remain
phase
h
serum
stimul
remain
phase
throughout
h
time
cours
figur
therefor
infect
prevent
cell
entri
phase
phase
understand
molecular
signal
pathway
modul
infect
collect
rd
cell
h
postinfect
express
relat
protein
western
blot
consist
abil
mediat
arrest
express
establish
mediat
cell
cycl
transit
phase
sherr
decreas
h
postinfect
express
partner
decreas
h
postinfect
figur
first
three
row
furthermor
express
known
inhibit
function
increas
cell
compar
mockinfect
cell
h
postinfect
figur
next
three
row
result
indic
pathway
pathway
activ
infect
regul
arrest
cell
phase
also
evalu
express
promot
cell
cycl
progress
phase
phase
darzynkiewicz
et
al
involv
mitot
progress
coverley
et
al
yam
et
al
express
decreas
h
postinfect
express
decreas
infect
time
point
test
figur
last
six
row
find
consist
abil
promot
exit
phase
base
establish
role
viral
nonstructur
protein
cellcycl
manipul
virus
goh
et
al
yuan
et
al
assess
whether
exogen
express
nonstructur
protein
might
mediat
arrest
result
demonstr
express
shift
cell
toward
phase
extent
arrest
phase
depend
dose
plasmid
transfect
r
p
similar
result
observ
r
p
figur
b
confirm
role
manipul
phase
transfect
pegfp
cell
analyz
success
transfect
cell
found
pegfptransfect
cell
ratio
cell
p
compar
pegfp
cell
p
compar
pegfp
meanwhil
three
group
nontransfect
cell
ratio
respect
figur
therefor
result
suggest
viral
protein
may
contribut
enhanc
percentag
cell
infect
primari
caus
agent
atyp
hfmd
epidemiolog
data
indic
outbreak
hfmd
markedli
increas
worldwid
recent
year
gao
et
al
laga
et
al
li
j
et
al
li
w
et
al
mirand
et
al
howev
although
pathogen
mechan
partli
studi
zhang
et
al
relationship
host
cell
clear
present
studi
relationship
host
cell
cycl
investig
result
demonstr
infect
induc
signific
cellcycl
arrest
phase
human
rhabdomyosarcoma
rd
cell
line
number
virus
creat
favor
environ
replic
manipul
host
cellcycl
chen
makino
helt
harri
dove
et
al
et
al
yu
et
al
therefor
result
consist
possibl
arrest
induc
might
serv
strategi
viral
prolifer
evalu
possibl
cell
cycl
synchron
execut
serum
depriv
thymidin
nocodazol
treatment
respect
result
show
synchron
promot
replic
viral
product
affect
viru
entri
howev
synchron
phase
decreas
viral
replic
inhibit
viral
product
result
suggest
phase
favor
product
phase
inhibitori
viral
product
previou
studi
determin
main
agent
lead
typic
hfmd
induc
cell
cycl
arrest
phase
facilit
product
yu
et
al
contrast
find
studi
result
surpris
given
belong
picornavirida
famili
caus
hfmd
although
know
reason
differ
could
explain
differ
characterist
region
epidem
europ
asia
symptom
clinic
scope
epidem
also
demonstr
human
enteroviru
altern
emerg
pathogen
caus
sever
respiratori
diseas
induc
cell
cycl
arrest
phase
wang
et
al
therefor
share
abil
regul
cell
cycl
progress
similar
result
studi
synchron
shown
inhibit
product
yu
et
al
therefor
treatment
either
typic
atyp
hfmd
symptom
agent
induc
cell
cycl
arrest
consid
cell
cycl
progress
control
bind
cdk
correspond
cyclin
exampl
regul
cell
cycl
cyclin
regul
cellular
sphase
entri
hind
et
al
coverley
et
al
yam
et
al
regul
mitot
process
yu
et
al
adeyemi
pintel
understand
mechan
arrest
induc
infect
host
protein
express
examin
includ
cyclin
protein
downregul
infect
though
timepoint
downregul
vari
furthermor
inhibitori
protein
upregul
infect
find
support
model
infect
arrest
phase
downregul
upregul
pathway
infect
inhibit
phase
entri
downregul
cyclin
express
infect
promot
exit
downregul
express
base
wellcharacter
associ
viral
nonstructur
protein
viral
replic
goh
et
al
yuan
et
al
yu
et
al
specul
viral
protein
respons
replic
might
manipul
cell
cycl
progress
result
prove
express
induc
cell
cycl
arrest
phase
indic
proteas
weng
et
al
lei
et
al
rnadepend
rna
polymeras
baltimor
richard
et
al
import
viral
product
therefor
studi
demonstr
new
function
protein
implic
put
target
strateg
develop
new
antivir
therapi
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
